A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.
Also called NCT02946541
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 160 participants
- Sponsor
- Registry
-
NCT02946541
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02946541. Randomized; quadruple masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2014-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- evogliptin 5mg
- Intervention (Drug)
- Placebo
- Lead sponsor
- Dong-A ST Co., Ltd.
Record details
- Record id
cardio:ct-nct02946541- Content hash
3bd2d06fedf4c451d6e7139476d051c9ca52353dc73cc55e6962ee0da379e4bc